Glow Blend Research Peptide Formulation COAs
View current and historical batch-specific testing results and Certificates of Analysis for Glow Blend Research Peptide Formulation.
70MG
Glow Blend Research Peptide Formulation batch testing
70MG Certificate of Analysis
Testing Explanation
Glow 70mg batches are independently analyzed by
Freedom Diagnostics
to verify product identity, purity, and net peptide content.
The available certificate covers
Glow 70mg,
with identity confirmed as
GHK-Cu/BPC-157/Thymosin Beta-4
through analytical testing.
Purity Standards
Verified Batch Results
The
Glow 70mg
certificate reports
99.516% purity,
with measured net peptide contents of
59.55 mg GHK-Cu,
11.93 mg BPC-157,
and
11.75 mg Thymosin Beta-4.
Storage
Storage Information
Specific storage conditions are
not listed
on the Freedom Diagnostics Certificate of Analysis for the
Glow 70mg
batch. The corresponding lot is
2026-03-001-G.
Testing Methodology
HPLC + Mass Spectrometry
Analytical testing for the
Glow 70mg
batch was performed using
HPLC with UV detection coupled with mass spectrometry.
Mass spectrometry
was used to confirm the identity of
GHK-Cu, BPC-157, and Thymosin Beta-4,
while
HPLC-UV
reported a purity result of
99.516%.
Glow Blend Research Peptide Formulation
View product information, specifications, research information and available variations.
View Glow Blend Research Peptide Formulation